First Citizens Bank & Trust’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
First Citizens Bank & Trust's NVO Position: Q2 2026 in Review
First Citizens Bank & Trust reduced its Novo Nordisk (NVO) stake by 0.87% in Q2 2026, selling an estimated $5.29K and leaving 14,029 shares worth $673K. The position accounts for 0.01% of the portfolio, ranked #394.
First Citizens Bank & Trust first reported a position in NVO in Q2 2022 and has held it in 17 quarters since. The position peaked at $2.28M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- First Citizens Bank & Trust held 14,029 shares of Novo Nordisk worth $673K as of Q2 2026.
- First Citizens Bank & Trust sold 123 Novo Nordisk shares in Q2 2026, an estimated $5.29K.
- Novo Nordisk made up 0.01% of First Citizens Bank & Trust's portfolio in Q2 2026, its #394 holding.
- First Citizens Bank & Trust first reported a position in Novo Nordisk in Q2 2022 and has held it in 17 quarters since.
- First Citizens Bank & Trust's Novo Nordisk position peaked at $2.28M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.